SCHEMBL30807261

SCHEMBL30807261

CC(C)(C)[Si](C)(C)OCCCCCNC(=O)c1ccccn1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.57
ALDH1A1 P00352 2/20 0.57
HDAC3 O15379 1/20 0.56
HDAC4 P56524 1/20 0.56
HDAC1 Q13547 1/20 0.56
HDAC7 Q8WUI4 1/20 0.56
HDAC2 Q92769 1/20 0.56
HDAC10 Q969S8 1/20 0.56
HDAC11 Q96DB2 1/20 0.56
HDAC8 Q9BY41 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
HDAC9 Q9UKV0 1/20 0.56
HDAC5 Q9UQL6 1/20 0.56
KMT2A Q03164 7/20 0.53
MEN1 O00255 3/20 0.53
ALOX15 P16050 1/20 0.52
NAMPT P43490 1/20 0.52
KDM4E B2RXH2 1/20 0.49
HTT P42858 1/20 0.49
KDM4C Q9H3R0 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27153136 0.81 MEN1 (0.40) SMN1; SMN2ALDH1A1HDAC3HDAC4HDAC1
SCHEMBL12895235 0.78 ALDH1A1 (0.74) SMN1; SMN2ALDH1A1HDAC3HDAC4HDAC1
SCHEMBL8044895 0.78 SMN1; SMN2 (0.70) SMN1; SMN2ALDH1A1HDAC3HDAC4HDAC1
SCHEMBL9095557 0.78 SMN1; SMN2 (0.70) SMN1; SMN2ALDH1A1HDAC3HDAC4HDAC1
SCHEMBL14786047 0.78 SMN1; SMN2 (0.70) SMN1; SMN2ALDH1A1HDAC3HDAC4HDAC1
SCHEMBL24795619 0.78 SMN1; SMN2 (0.70) SMN1; SMN2ALDH1A1HDAC3HDAC4HDAC1
SCHEMBL9941474 0.78 SMN1; SMN2 (0.70) SMN1; SMN2ALDH1A1HDAC3HDAC4HDAC1
SCHEMBL20340796 0.78 SMN1; SMN2 (0.70) SMN1; SMN2ALDH1A1HDAC3HDAC4HDAC1
SCHEMBL8516755 0.77 SMN1; SMN2 (0.90) SMN1; SMN2ALDH1A1HDAC3HDAC4HDAC1
SCHEMBL19169564 0.77 SMN1; SMN2 (0.68) SMN1; SMN2ALDH1A1HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577211-A2 PEROXIREDOXIN 3 INHIBITORS AND METHODS OF USE FOR TREATING CANCER Wake Forest University Health Sciences (US) 2025-07-02 EP disclosed
WO-2024044744-A2 PEROXIREDOXIN 3 INHIBITORS AND METHODS OF USE FOR TREATING CANCER WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) 2024-02-29 WO disclosed